These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10774771)

  • 1. Risk assessment for possible carcinogens: a critical look.
    Farber E
    Drug Metab Rev; 2000 May; 32(2):143-51. PubMed ID: 10774771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of tests for cell transformation and gap-junction intercellular communication for detecting nongenotoxic carcinogenic activity.
    Swierenga SH; Yamasaki H
    IARC Sci Publ; 1992; (116):165-93. PubMed ID: 1428080
    [No Abstract]   [Full Text] [Related]  

  • 3. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beware of a new carcinogenic risk: promotion of promoters.
    Bounias M; Bonaly A
    Toxicol Lett; 1995 Oct; 80(1-3):19-24. PubMed ID: 7482586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxic and carcinogenic effects of gastrointestinal drugs.
    Brambilla G; Mattioli F; Martelli A
    Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
    Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
    Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
    Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
    IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens.
    Yamasaki H
    Mutat Res; 1996 Sep; 365(1-3):91-105. PubMed ID: 8898991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor promotion: models and assay systems.
    Fitzgerald DJ; Yamasaki H
    Teratog Carcinog Mutagen; 1990; 10(2):89-102. PubMed ID: 1973858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of chemically induced cell proliferation in carcinogenesis and its use in health risk assessment.
    Croy RG
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):289-302. PubMed ID: 8013422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation.
    Verna L; Whysner J; Williams GM
    Pharmacol Ther; 1996; 71(1-2):83-105. PubMed ID: 8910950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical carcinogenesis.
    Cohen SM; Arnold LL
    Toxicol Sci; 2011 Mar; 120 Suppl 1():S76-92. PubMed ID: 21147961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic events during the process of cell transformation induced by carcinogens (review).
    Nguyen-Ba G; Vasseur P
    Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is current risk assessment of non-genotoxic carcinogens protective?
    Braakhuis HM; Slob W; Olthof ED; Wolterink G; Zwart EP; Gremmer ER; Rorije E; van Benthem J; Woutersen R; van der Laan JW; Luijten M
    Crit Rev Toxicol; 2018 Jul; 48(6):500-511. PubMed ID: 29745287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls in assessing risks from carcinogens.
    Furst A
    Biomed Environ Sci; 1991 Sep; 4(3):242-9. PubMed ID: 1764213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IARC classes 1 and 2 carcinogens are successfully identified by an alternative strategy that detects DNA-reactivity and cell transformation ability of chemicals.
    Benigni R; Bossa C; Battistelli CL; Tcheremenskaia O
    Mutat Res Genet Toxicol Environ Mutagen; 2013 Dec; 758(1-2):56-61. PubMed ID: 24076401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenesis: basic principles.
    Couch DB
    Drug Chem Toxicol; 1996 Aug; 19(3):133-48. PubMed ID: 8933020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.